The WACC of Harvard Bioscience Inc (HBIO) is 9.1%.
| Range | Selected | |
| Cost of equity | 8.90% - 11.90% | 10.40% |
| Tax rate | 11.50% - 22.20% | 16.85% |
| Cost of debt | 6.30% - 7.00% | 6.65% |
| WACC | 8.0% - 10.2% | 9.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.1 | 1.26 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.90% | 11.90% |
| Tax rate | 11.50% | 22.20% |
| Debt/Equity ratio | 0.37 | 0.37 |
| Cost of debt | 6.30% | 7.00% |
| After-tax WACC | 8.0% | 10.2% |
| Selected WACC | 9.1% | |